Practitioner-Led Field Execution: Scaling MedTech Validation Across Public Healthcare Networks in Breast Cancer Screening

divider
Scaling Breast Cancer Screening: 22-Facility MedTech Trial Case Study

Overview

A regional health deployment evaluating an AI-driven, non-invasive screening technology across 22 primary and secondary public healthcare facilities. The goal was to establish real-world evidence (RWE), validate field workflows, and optimize patient referral pathways.

Challenge

A MedTech innovation team required an experienced clinical and operational partner to govern a large-scale field trial, ensure compliance across 22 facilities, and build the evidence base for market entry.

breast cancer screening device-designial
Cervical Imaging & Screening Device-designial-designial

Solution

How Our Leadership Governed Execution:

  • Clinical Governance (Chief Medical Officer Guidance): Defined trial protocols, addressed edge-case diagnostics, and validated screening accuracy under real-world clinical conditions.
  • Operational Command (Operations Director Guidance): Governed field logistics, technical troubleshooting, and daily data integrity across 3 regional districts.
  • Team Enablement: Supervised multi-disciplinary field teams to train front-line health workers, ensuring zero workflow friction and high patient acceptance.

Key Results & Field Data

Key Performance Metrics:

  • 7,700+ Patient Scans Completed
  • 22 Public Healthcare Facilities Onboarded
  • 12.3% Abnormal Capture Rate for Follow-up Care
  • 15-Min Average Scan & AI Analysis Time

How this applies to your MedTech platform?

Scalanova Health leverages practitioner-led governance and multi-site execution frameworks to help MedTech innovators validate clinical accuracy, prove operational viability, and accelerate global market entry.